Pyxis Oncology, Inc.

PYXS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$22-$18-$21-$36
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$3$4$3
Change in WC$5-$2-$5-$7
Other Non-Cash$3-$1-$1$20
Operating Cash Flow-$13-$17-$23-$19
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$15-$41-$51-$4
Inv. Sales/Matur.$26$56$67$31
Other Inv. Act.$0$0$0$0
Investing Cash Flow$11$15$16$27
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0-$0$0
Financing Cash Flow-$0-$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$2-$7$7
Supplemental Information
Beg. Cash$12$14$21$14
End Cash$10$12$14$21
Free Cash Flow-$13-$17-$23-$19